Tech Transfer Note: Empowering local laboratories with somatic testing for adult solid tumors

Whether your lab is well-versed in next-generation sequencing (NGS) testing or is just launching a precision medicine strategy, has simple internal set-up or requires integration of a new test into existing complex systems, Canexia Health will work with you from initial planning to production launch.

This technical note describes the NGS assays developed by Canexia Health for somatic testing of adult solid tumors and how they are made available through local laboratories via our proprietary technology transfer model.